Weil Company, Inc. Dexcom Inc Transaction History

Weil Company, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$94.08 - $130.2 $56,918 - $78,771	-605 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $22,942 - $30,783	-215 Reduced 26.22%	605 $331,000
Q2 2021 Jul 20, 2021	SELL	$80.99 - $107.93 $50,213 - $66,916	-620 Reduced 43.06%	820 $350,000
Q1 2021 May 12, 2021	SELL	$84.79 - $104.74 $15,686 - $19,376	-185 Reduced 11.38%	1,440 $518,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $12,903 - $20,420	-270 Reduced 14.25%	1,625 $438,000
Q3 2018 Nov 07, 2018	BUY	$23.35 - $36.72 $44,248 - $69,584	1,895 New	1,895 $271,000
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $89,366 - $128,495	-5,095 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $56,656 - $78,361	5,095	5,095 $292,000

1,041

356M

5.51M

5.61M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.